FDA, Harvard-MIT To Collaborate On Clinical Trial Design
This article was originally published in The Pink Sheet Daily
Executive Summary
A workshop on improving clinical trial design and joint research on “more theoretical statistical questions” are part of a collaboration outlined in a memorandum of understanding.